321,527 Shares in SOPHiA GENETICS SA $SOPH Purchased by Archon Capital Management LLC

Archon Capital Management LLC bought a new stake in shares of SOPHiA GENETICS SA (NASDAQ:SOPH) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 321,527 shares of the company’s stock, valued at approximately $997,000. Archon Capital Management LLC owned 0.48% of SOPHiA GENETICS as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently modified their holdings of the business. Silverberg Bernstein Capital Management LLC increased its holdings in SOPHiA GENETICS by 31.8% during the second quarter. Silverberg Bernstein Capital Management LLC now owns 45,715 shares of the company’s stock valued at $142,000 after buying an additional 11,040 shares during the period. Federated Hermes Inc. increased its holdings in shares of SOPHiA GENETICS by 89.0% in the 1st quarter. Federated Hermes Inc. now owns 189,000 shares of the company’s stock valued at $627,000 after acquiring an additional 89,000 shares during the period. Rathbones Group PLC bought a new position in shares of SOPHiA GENETICS in the 2nd quarter worth $504,000. Ensign Peak Advisors Inc purchased a new stake in shares of SOPHiA GENETICS during the 2nd quarter worth $775,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in SOPHiA GENETICS by 246.9% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 7,632,871 shares of the company’s stock valued at $25,341,000 after purchasing an additional 5,432,871 shares in the last quarter. Hedge funds and other institutional investors own 31.59% of the company’s stock.

SOPHiA GENETICS Price Performance

Shares of SOPH opened at $5.02 on Friday. The company has a debt-to-equity ratio of 0.78, a current ratio of 2.80 and a quick ratio of 2.62. The company’s fifty day moving average price is $4.47 and its 200-day moving average price is $3.67. SOPHiA GENETICS SA has a 1-year low of $2.58 and a 1-year high of $5.30. The firm has a market capitalization of $339.25 million, a PE ratio of -10.91 and a beta of 1.10.

SOPHiA GENETICS (NASDAQ:SOPH) last issued its quarterly earnings results on Tuesday, November 4th. The company reported ($0.30) EPS for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.10). The firm had revenue of $19.46 million for the quarter, compared to analyst estimates of $18.13 million. SOPHiA GENETICS had a negative return on equity of 37.75% and a negative net margin of 41.13%. On average, equities research analysts predict that SOPHiA GENETICS SA will post -0.96 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on SOPH shares. BTIG Research boosted their target price on shares of SOPHiA GENETICS from $6.00 to $7.00 and gave the stock a “buy” rating in a report on Monday, November 10th. Wall Street Zen upgraded shares of SOPHiA GENETICS to a “hold” rating in a research note on Saturday, November 1st. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of SOPHiA GENETICS in a research note on Wednesday, October 8th. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $9.00.

SOPHiA GENETICS Profile

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific.